Brief: Calmark's First Product, Neo-Bilirubin, Obtains CE Mark
April 21 (Reuters) - Calmark Sweden AB CALMAb.TE :
* CALMARK'S FIRST PRODUCT, NEO-BILIRUBIN, OBTAINS CE MARK
* CALMARK SWEDEN AB - CALMARK'S FIRST PRODUCT,
NEO-BILIRUBIN,
OBTAINS CE MARK
* CALMARK SWEDEN AB - PRODUCT CAN NOW BE SOLD TO AND USED IN
HEALTHCARE WITHIN EUROPEAN UNION
Source text for Eikon: ID:nWkrb3Bxww
Further company coverage: CALMAb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Calmark Sweden AB
See all newsBrief: Calmark Sweden AB Says Signs Distributor Agreement for India Regarding COVID-19-LDH
Brief: Calmark Signs Distributor Agreement With Enox Pharma For Five Key Markets In The Middle East
Brief: Calmark Sweden Q4 Oper Loss Widens To SEK 4.0 Mln
Brief: Calmark Sweden Signs Distribution Deal With LabForce In Switzerland
Brief: Calmark Sweden Raises SEK 26.5 Mln In Oversubscribed Rights Issue